Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06508775

Title field or adapter rule

{'original_value': 'Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:36.778307+00:00

Published At

2026-10-09T00:00:00+00:00

Record Updated At

2026-10-09

Source Retrieved At

2026-10-31T22:19:02.163121+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Melanoma Stage III", "B-cell Non Hodgkin Lymphoma", "Pediatric ALL", "Childhood Non-Hodgkin Lymphoma", "Acute Lymphatic Leukemia", "Chronic Lymphatic Leukemia", "Melanoma Stage IV"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-09", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06508775"

protocolSection.identificationModule.officialTitle

"Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Melanoma Stage III (protocolSection.conditionsModule.conditions)
• B-cell Non Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Pediatric ALL (protocolSection.conditionsModule.conditions)
• Childhood Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Acute Lymphatic Leukemia (protocolSection.conditionsModule.conditions)
• Chronic Lymphatic Leukemia (protocolSection.conditionsModule.conditions)
• Melanoma Stage IV (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Long-term follow-up of CAR T cell therapy'], 'description': 'Assessment of long-term safety and efficacy of MB-CART19.1 treatment.', 'name': 'MB-CART19.1', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Long-term follow-up of CAR T cell therapy'], 'description': 'Assessment of long-term safety and efficacy of MB-CART20.1 treatment.', 'name': 'MB-CART20.1', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Long-term follow-up of CAR T cell therapy'], 'description': 'Assessment of long-term safety and efficacy of MB-CART2019.1 treatment.', 'name': 'MB-CART2019.1', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.